MINI FUTURE SHORT - PFIZER INC | Real-time Euronext Paris 04:28:04 22/05/2024 pm IST | ||
| 6.94 EUR | -0.57% |
|
| Current month | -29.64% | ||
| 1 month | -29.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 22/24/22 | 6.94 | -0.57% |
| 21/24/21 | 6.98 | +3.87% |
| 20/24/20 | 6.72 | -0.59% |
| 17/24/17 | 6.76 | +3.05% |
| 16/24/16 | 6.56 | +1.39% |
Real-time Euronext Paris
Last update May 22, 2024 at 04:28 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| 9P4MB | |
| ISIN | NLBNPNL2KFK7 |
| Date issued | 15/11/2023 |
| Strike | 35.94 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 6.79 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.46 € |
|---|---|
| Lowest since issue | 5.19 € |
| Spread | 0.24 € |
| Spread % | 3.40% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.56
USD
Average target price
31.94
USD
Spread / Average Target
+11.83%
- Stock Market
- Certificates
- 9P4MB Certificat